Table 6 Post-procedural complications.
ALL n = 74 | EP n = 43 | PD n = 31 | p-value | |
|---|---|---|---|---|
Early adverse events, n (%) | – | – | – | – |
Adverse events of EP | – | – | – | – |
Pancreatitis | – | 13 (30.2) | – | – |
Mild/moderate | – | 12 (27.9) | – | – |
Severe | – | 1 (2.3) | – | – |
Hemorrhage | 10 (23.2) | |||
Perforation | – | 1 (2.3) | – | – |
Adverse events of PD | – | – | – | |
Hemorrhage | – | – | 2 (6.5) | – |
Pancreatic fistula | – | – | 13 (41.9) | – |
Bile leak | – | – | 1 (3.2) | – |
CDC | – | – | – | – |
I | 19 (25.6) | 1 (2.3) | 18 (58.0) | < 0.001 |
II | 27 (36.5) | 14 (32.6) | 13 (41.9) | 0.318 |
IIIa | 17 (23.0) | 9 (20.9) | 8 (25.8) | 0.571 |
IIIb | 1 (1.4) | 0 | 1 (3.2) | 0.152 |
IVa | 3 (4.1) | 1 (2.3) | 2 (6.5) | 0.557 |
IVb, V | 0 | 0 | 0 | – |
Severe complications | 4 (5.4) | 1 (2.3) | 3 (9.6) | 0.302 |
Median CCI (range) | 20.9 (0–54.1) | 14.8 (0–54.1) | 22.6 (0–43.3) | 0.002 |
Late adverse events n (%) | – | – | – | – |
Cholangitis | – | 2 (4.7) | 3 (9.6) | – |
Pancreatitis | – | 4 (9.3) | 1 (3.2) | – |
Perforation | – | – | 1 (3.2) | – |
